PQE Group Creates an Internal Research Task Force to Fight Fake News in Relation to COVID-19
Global Encryption Software Market (2020 to 2025) - Increased Adoption of Encryption Software Across Verticals Presents Opportunities - ResearchAndMark
New Partnership of RIDDLE&CODE and S1Seven to Revolutionise the Metal Industry
Passenger Vehicle Telematics Market Analysis Highlights the Impact of COVID-19 2020-2024 | Regulatory Mandates to Improve Vehicle Safety to Boost the
Human Capital Management Market by Software, Services, Deployment Model, Organization Size, and Region - Global Forecast to 2025 - ResearchAndMarkets.
Metal Tiger plc UK Regulatory Announcement: Pan Asia Metals – Planned IPO and Corporate Update
Marathon Asset Manag UK Regulatory Announcement: Form 8.3 - Georgia Capital plc
BARCLAYS PLC UK Regulatory Announcement: Form 8.3 - AON Amendment
COVID-19: Significant Shift in Strategy of Internet Protocol (IP) Camera Market 2020-2024 | Rise in Adoption of Smart Homes to Augment Growth | Techna
AVATAMED Partners CBmed in Europe on Precision Cancer Project
-
FT Indxx Innovative Transaction & Process UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 10.07.2020 LEGR LN IE00BF5DXP42 1,750,002.00 USD 38,895,117.75 22.226 Contacts First Trust Global Funds PLC
-
FT US Small Cap Core AlphaDEX UCITS ETF UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Small Cap Core AlphaDEX UCITS ETF 10.07.2020 FYX LN IE00BDBRT036 50,002.00 USD 1,018,905.61 20.377 Contacts First Trust Global Funds PLC
-
FT US Equity Income ETF UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 10.07.2020 UINC IE00BZBW4Z27 2,100,002.00 USD 38,227,628.92 18.204 Contacts First Trust Global Funds PLC
-
FT United Kingdom AlphaDEX ETF UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 10.07.2020 FKU IE00B8X9NZ57 740,002.00 GBP 14,990,102.93 20.257 Contacts First Trust Global Funds PLC
-
FT ETF US IPO Index UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 10.07.2020 FPX. IE00BYTH6238 300,002.00 USD 9,868,162.20 32.894 Contacts First Trust Global Funds PLC
-
FT Eurozone AlphaDEX UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 10.07.2020 FEUD IE00BF2FL590 620,002.00 EUR 18,202,180.46 29.358 Contacts First Trust Global Funds PLC
-
FT ETF Global Equity UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 10.07.2020 GINC LN IE00BD842Y21 505,002.00 USD 18,756,949.10 37.142 Contacts First Trust Global Funds PLC
-
FT Defined Eurozone AlphaDex ETF UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 10.07.2020 FEUZ IE00B8X9NY41 3,930,002.00 EUR 111,706,322.81 28.424 Contacts First Trust Global Funds PLC
-
FT ETF Global Equity UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 10.07.2020 FGBL.LN IE00BYTH6121 45,002.00 USD 1,943,561.85 43.188 Contacts First Trust Global Funds PLC
-
FT Japan AlphaDEX ETF UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Japan AlphaDEX UCITS ETF 10.07.2020 FJP IE00BWTNM743 50,002.00 JPY 114,500,752.94 2,289.923 Contacts First Trust Global Funds PLC
-
FT Emerging Markets AlphaDEX ETF UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 10.07.2020 FEM IE00B8X9NX34 1,400,002.00 USD 38,628,216.92 27.592 Contacts First Trust Global Funds PLC
-
FT UK AlphaDEX UCITS ETF Class B UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 10.07.2020 FKUD IE00BD9N0445 110,002.00 GBP 1,853,406.30 16.849 Contacts First Trust Global Funds PLC
-
FT US Large Cap Core AlphaDEX ETF UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 10.07.2020 FEXD IE00BWTNMB87 775,002.00 USD 34,475,627.55 44.485 Contacts First Trust Global Funds PLC
-
First Trust Cloud Computing UCITS ETF UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 10.07.2020 CPQ IE00BFD2H405 9,800,002.00 USD 320,139,999.05 32.667 Contacts First Trust Global Funds PLC
-
SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent
TIANJIN, China, July 13, 2020 /PRNewswire/ -- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, the company plans to submit the data to the U.S. Food and Drug Administration and Japanese Pharmaceuticals and Medical Devices Agency for the device approval. "Despite the problems of managing the COVID pandemic, everyone involved in the study has made a tremendous effort to finish the necessary clinical follow-up," said Martin B. Leon, MD, Columbia University Medical Center, USA, and Chairman of the Executive Committee of the PIONEER III study. "We can now focus on analyzing the data and planning the presentation and publication of the findings in the second half of 2020. The completion of this study could help lead SINOMED to become the first Chinese company to gain FDA approval of a drug-eluting stent." The PIONEER III trial completed follow-up of 1,631 patients at 74 sites in North America, Europe and Japan. Patients presenting with symptomatic heart disease were randomized 2:1 to receive the BuMA Supreme DES or any commercially available durable polymer everolimus-eluting stent. The clinical trial's endpoint is target lesion failure (TLF) at twelve months and patients will be followed-up for five years post study enrollment. Additionally, the trial is powered for a long-term landmark analysis of TLF between one and five years; looking for superiority of the BuMA Supreme over the control arm. The BuMA Supreme is a new evolution of DES, developed to maximize functional healing of the blood vessels after a stent implantation. Its innovative design utilizes a combination of a novel drug release kinetic and proprietary coating technology to allow for a quicker return of natural cellular functionality, in comparison to other commercially available DES. This healthy restoration is believed to contribute to better long-term clinical outcomes. The BuMA Supreme with a new cobalt chromium platform and delivery system is CE approved and available for distribution in select regions. BuMA Supreme is an investigational device in the United States and Japan. About SINOMED Sino Medical Science Technology Inc. (SINOMED), a global medical device company engaged in research, development, production and commercial distribution of interventional devices. We are focused on developing breakthrough technologies to target unmet clinical needs in the interventional treatment of coronary, neurovascular and structural heart disease. For more information, visit: www.sinomed.com Logo - https://mma.prnasia.com/media2/950402/Sinomed_Logo.jpg?p=medium600 Contact: SINOMED B.V Cindy Zheng Wilhelminakade 173 3072AP Rotterdam The Netherlands T: +31 10 307 6295 E: cindy.zheng@sinomed.com
-
FT Dow Jones Internet UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 10.07.2020 FDNU IE00BG0SSC32 750,002.00 USD 19,153,425.54 25.538 Contacts First Trust Global Funds PLC
-
FT Nasdaq Cybersecurity UCITS ETF UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 10.07.2020 NQCYBRN IE00BF16M727 1,200,002.00 USD 26,792,911.22 22.327 Contacts First Trust Global Funds PLC
